Disruptive Pharma AB (publ) (FRA:5LH0)

Market Cap	4.22M
Revenue (ttm)	n/a
Net Income	n/a
EPS	n/a
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,000
Open	0.0778
Previous Close	0.0717
Day's Range	0.0778 - 0.0778
52-Week Range	0.0001 - 2.2700
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 19, 2026

About Disruptive Pharma AB

Disruptive Pharma AB (publ) operates as a pharmaceutical technology company in Sweden. The company develops and commercializes Formulite, a patented and clinically evaluated platform technology for oral drug formulation and drug product development. The company is based in Stockholm, Sweden.

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2021
• Country: Sweden
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 5LH0

Financial Performance

Financial numbers in SEK

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Oct 26, 2026

Data Sources Report a data error